KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crescent Capital BDC (CCAP) EBT (2021 - 2025)

Crescent Capital BDC's EBT history spans 5 years, with the latest figure at $17.0 million for Q4 2025.

  • For Q4 2025, EBT fell 17.47% year-over-year to $17.0 million; the TTM value through Dec 2025 reached $68.6 million, down 24.27%, while the annual FY2025 figure was $68.6 million, 24.27% down from the prior year.
  • EBT reached $17.0 million in Q4 2025 per CCAP's latest filing, down from $17.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $24.2 million in Q3 2024 to a low of $12.3 million in Q1 2022.
  • Average EBT over 5 years is $18.3 million, with a median of $17.2 million recorded in 2025.
  • Peak YoY movement for EBT: soared 43.95% in 2023, then fell 28.87% in 2025.
  • A 5-year view of EBT shows it stood at $13.3 million in 2021, then rose by 21.47% to $16.2 million in 2022, then skyrocketed by 43.05% to $23.2 million in 2023, then fell by 11.2% to $20.6 million in 2024, then fell by 17.47% to $17.0 million in 2025.
  • Per Business Quant, the three most recent readings for CCAP's EBT are $17.0 million (Q4 2025), $17.2 million (Q3 2025), and $17.3 million (Q2 2025).